Prime Medicine, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €2.64M +5.8% -€171.60M -1.6% -6,489.7% +4.9 pp N/A N/A
    (estimated) €2.50M -91.6% -€174.39M +21.6% -6,978.2% -65 pp N/A N/A
    (estimated) €29.71M +43.0% -€143.43M +7.1% -482.8% +1.6 pp -€93.71M +3.5% -315.4% +1.2 pp
    (estimated) €20.78M +179.0% -€133.90M -13.4% -644.4% +14 pp -€90.52M -29.4% -435.6% +13 pp
    (estimated) €7.45M +192.7% -€154.54M -7.5% -2,075.4% +45 pp -€128.26M +30.1% -1,722.5% +22 pp
    €2.54M +∞% -€167.08M -1.1% -6,566.6% -66 pp -€98.58M -26.2% -3,874.3% -39 pp
    €0.00 +NaN% -€169.00M +62.6% N/A -€133.65M +35.4% N/A
    €0.00 +NaN% -€103.91M -26.3% N/A -€98.71M +286.6% N/A
    €0.00 -100.0% -€141.05M +4,749.5% N/A -€25.53M +510.2% N/A
    €4.44M +∞% -€2.91M +34.8% -65.5% -0.65 pp -€4.18M +267.7% -94.1% -0.94 pp
    €0.00 -€2.16M N/A -€1.14M N/A

    Notifications